IHC - Hepatitis B Surface Antigen (HBsAg)

The IHC – Hepatitis B Surface Antigen (HBsAg) test is a specialized immunohistochemistry (IHC) diagnostic test used to detect the presence of Hepatitis B Surface Antigen (HBsAg) in liver tissue samples. This test helps confirm Hepatitis B virus (HBV) infection and provides important information about viral activity within liver cells.

HBsAg is a protein found on the outer surface of the Hepatitis B virus. Detecting this antigen in liver tissue helps pathologists identify infected liver cells and assess the extent of viral involvement. This test is commonly performed on liver biopsy specimens, especially when blood test findings need further confirmation through tissue-level examination.

The HBsAg IHC test is particularly useful in diagnosing chronic Hepatitis B infection, evaluating liver damage caused by the virus, and monitoring disease progression. It also helps specialists determine how actively the virus is affecting liver tissue, which supports clinical decision-making.

Benefits of the Test

The IHC HBsAg test offers several diagnostic advantages:

• Detects Hepatitis B viral surface antigen directly in liver tissue
• Confirms HBV infection at the cellular level
• Assesses liver involvement and disease severity
• Helps monitor chronic Hepatitis B progression
• Supports treatment planning and prognosis evaluation
• Provides accurate tissue-based confirmation when blood results are unclear

This test gives pathologists direct evidence of viral presence inside liver cells.

Why Doctors Recommend This Test

Doctors recommend the HBsAg IHC test when liver biopsy analysis is needed to evaluate suspected or confirmed Hepatitis B infection. It is especially useful in patients with:

• Chronic Hepatitis B infection
• Abnormal liver biopsy findings
• Elevated liver enzymes of unknown cause
• Suspected viral replication activity
• Detailed liver disease assessment needs

This test helps hepatologists and pathologists understand viral activity and tissue damage more accurately.

Preparation Before Test

No special preparation is required for the IHC test itself. It is performed on previously collected liver biopsy tissue samples. Patients should follow their doctor’s instructions regarding biopsy preparation and recovery.

Normal Reporting Time

The usual reporting time for the HBsAg IHC test is 3 to 5 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients diagnosed with chronic Hepatitis B
• Individuals undergoing liver biopsy evaluation
• Patients with unexplained liver inflammation
• Cases requiring tissue confirmation of HBV infection
• Patients being monitored for liver disease progression

The IHC HBsAg test is an important tool in liver pathology. It helps confirm Hepatitis B infection directly in liver tissue and provides valuable insights into viral activity and disease severity. Early and accurate detection supports timely treatment and better long-term liver care.